MEDTR vs TUPRS Comparison
Price, market cap, valuation, profitability and leverage metrics of MEDTR and TUPRS side by side.
If You Had Invested TRY 10,000
Metric Comparison
| Metric | MEDTR | TUPRS | Sector median |
|---|---|---|---|
| Last price (TL) | 17.70 | 340.50 | 10.69 |
| Daily change | 3.63% | −0.87% | −1.10% |
| Market cap | TRY 2.1B | TRY 656.1B | TRY 2.9B |
| P/E | 58.48 | 9.10 | 11.70 |
| P/B | 0.61 | 1.45 | 0.79 |
| Dividend yield | 0.66% | 1.78% | 1.06% |
| Return on equity | 1.14% | 18.20% | 1.14% |
| Free float | 20.21% | 49.04% | 36.14% |
Popular Comparisons
Related Pages
About the MEDTR vs TUPRS Comparison
Price, market cap, valuation multiples, profitability and leverage of MEDTR (Meditera Tibbi Malzeme) and TUPRS (Tüpraş) side by side as of Nov 2, 2026, 16:20. Of the 15 metrics compared, MEDTR leads in 6 and TUPRS leads in 9.
Highlights: Daily change: MEDTR leads (3.63% vs −0.87%). Market cap: TUPRS leads (TRY 656.1B vs TRY 2.1B). P/E: TUPRS leads (9.10 vs 58.48). P/B: MEDTR leads (0.61 vs 1.45). EV/EBITDA: TUPRS leads (5.24 vs 6.47). EV/Sales: TUPRS leads (0.80 vs 1.16). Dividend yield: TUPRS leads (1.78% vs 0.66%). Gross margin: MEDTR leads (33.71% vs 12.69%).
Frequently Asked Questions
Is MEDTR or TUPRS cheaper?
By P/E, TUPRS is cheaper (58.48 vs 9.10); by P/B, MEDTR trades at the lower multiple (0.61 vs 1.45).
Which is more profitable, MEDTR or TUPRS?
Annual net margin is 1.35% for MEDTR and 7.07% for TUPRS; return on equity is 1.14% for MEDTR and 18.20% for TUPRS.
Which is more leveraged, MEDTR or TUPRS?
The leverage ratio is 15.79 for MEDTR and 46.13 for TUPRS; net debt/EBITDA is — for MEDTR and −1.23 for TUPRS. Lower values mean less leverage.
Where does the comparison data come from?
Prices and market caps come from 15-minute delayed Borsa Istanbul data; ratios are calculated from the latest financial statements filed with KAP. Some ratios are not defined for banks and insurers.